High unbound flucloxacillin fraction in critically ill patients.

Autor: Wallenburg E; Department of Pharmacy and Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands., Ter Heine R; Department of Pharmacy and Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands., de Lange DW; Department of Intensive Care and Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, The Netherlands., van Leeuwen H; Department of Intensive Care, Rijnstate, Arnhem, The Netherlands., Schouten JA; Department of Intensive Care, Radboud university medical center, Nijmegen, The Netherlands.; Department of Intensive Care, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.; Radboudumc Center for Infectious Diseases, Nijmegen, The Netherlands., Ten Oever J; Radboudumc Center for Infectious Diseases, Nijmegen, The Netherlands.; Department of Internal Medicine, Radboud university medical center, Nijmegen, The Netherlands., Kolwijck E; Department of Medical Microbiology, Radboud university medical center, Nijmegen, The Netherlands., Burger DM; Department of Pharmacy and Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.; Radboudumc Center for Infectious Diseases, Nijmegen, The Netherlands., Pickkers P; Department of Intensive Care, Radboud university medical center, Nijmegen, The Netherlands.; Radboudumc Center for Infectious Diseases, Nijmegen, The Netherlands., Gieling EM; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands., de Maat MM; Department of Pharmacy, Rijnstate, Arnhem, The Netherlands., Frenzel T; Department of Intensive Care, Radboud university medical center, Nijmegen, The Netherlands., Brüggemann RJ; Department of Pharmacy and Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.; Radboudumc Center for Infectious Diseases, Nijmegen, The Netherlands.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Nov 12; Vol. 76 (12), pp. 3220-3228.

Higher Dosage of Ciprofloxacin Necessary in Critically Ill Patients: A New Dosing Algorithm Based on Renal Function and Pathogen Susceptibility.

Autor: Gieling EM; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Clinical Pharmacy, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Wallenburg E; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Frenzel T; Department of Intensive Care, Radboud University Medical Center, Nijmegen, The Netherlands., de Lange DW; Department of Intensive Care and Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, The Netherlands., Schouten JA; Department of Intensive Care, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Intensive Care, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Ten Oever J; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Kolwijck E; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Burger DM; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Pickkers P; Department of Intensive Care, Radboud University Medical Center, Nijmegen, The Netherlands., Ter Heine R; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Brüggemann RJM; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Oct; Vol. 108 (4), pp. 770-774. Date of Electronic Publication: 2020 May 15.

Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.

Autor: Gieling EM; Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., van den Ham HA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands., van Onzenoort H; Radboud University Medical Centre, Nijmegen, The Netherlands., Bos J; Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Kramers C; Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.; Department of Pharmacology-Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands., de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands., de Vries F; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands.; Division of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands.; MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, UK., Burden AM; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands.; Division of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2017 Aug; Vol. 83 (8), pp. 1844-1859. Date of Electronic Publication: 2017 Mar 24.